We read your public website, and nothing else. Every claim below shows the evidence behind it, so you can check or dismiss any of it in seconds. The last section sets out what we could not see.
Where the gaps are
Where we would start
1. Regulatory and compliance
Confidence: well evidenced
What this covers Sector specific authorisation, licensing, supervisory relationships.
The evidence this rests on Medical device development (olfactory sensors for disease detection) Source: https://anemolabs.com
If this stays unfilled for six months Medical device and diagnostics claims (disease detection, biomarker screening) attract regulatory scrutiny (e.g. MHRA/FDA classification, clinical evidence standards). Without a named regulatory owner, the company risks building product and marketing claims that are not defensible for the intended regulatory pathway, causing costly rework or delayed market access.
Who fills it Has held a regulated role or run a compliance function in the specific sector. Not a generalist lawyer. Ask us who we have for this
Three questions for the first twenty minutes
Which regime applies to you, and are you authorised or exempt
Who is the accountable person today
What happens in your first supervisory conversation
2. Fractional CFO and financial control
Confidence: evidenced
What this covers Runway modelling, unit economics, board reporting, raise readiness.
The evidence this rests on Raised £700K to digitise smell Source: https://anemolabs.com
If this stays unfilled for six months Without dedicated financial oversight, runway modelling, burn tracking, and investor reporting fall to a technical or generalist founder, increasing the risk of cash mismanagement or being under-prepared for the next funding round.
Who fills it Has taken a company through at least one priced round. Comfortable at both the model and the board pack. Ask us who we have for this
Three questions for the first twenty minutes
How many months of runway do you have, and what assumption is that most sensitive to
What is your gross margin per unit, and how confident are you in it
Who currently owns the board pack
What you can do about it
Connectd keeps a bench of senior operators. We place up to three of them into a company like yours as advisors
or non executives, for three to six months.
Every one of them has been through our vetting and is actively looking for a board or advisory seat, so this is a shortlist we draw from, not a directory you search yourself.
The 2 gaps above are written as a brief for exactly that reason. Each one names the experience that fills it and the questions to put to whoever we introduce, so you are judging the person rather than taking our word for the match.
What happens if you say yes
A short call with someone on our team, usually the same week
We come back with named people against the gaps you agree are real
You meet them. If the fit is wrong, you say so and we go again
Three to six months, unpaid, no notice period and no fee at any point
If the gaps we named are the wrong ones, say so on the call. Getting that wrong is more useful to us than you politely agreeing.
The emailed copy and the forward to a co founder are available in
the tool itself, which is where the address can actually be captured.
What we would need to ask you
The Scientific Advisory Board section has a heading but no members rendered, is this a real, staffed advisory function or an aspirational placeholder?
The 'Backed By' section has a heading but no investor names or logos rendered, who, if anyone, are the institutional backers behind the £700K raise?
No pricing, customer logos, or specific product specifications are visible, is the product still pre-commercial, and if so, does that change the urgency of some of these gaps?
Things your site did not tell us
Pricing information
Number of employees beyond founding team
Some of your site we could not read. 2 pages build content with scripts we do not run. Nothing above rests on something appearing to be missing from those pages.
Where this came from
What we understood you to do Olfactory sensors combining proprietary hardware with in-house AI models for disease detection and biomarker monitoring through non-invasive screening of volatile organic compounds (VOCs) in bodily fluids
Who we understood you to sell to Healthcare sector for early disease detection and health monitoring